GTx, Inc. (NASDAQ:GTXI)

CAPS Rating: 3 out of 5

A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.

Results 1 - 20 of 20

Recs

1
Member Avatar zzlangerhans (99.67) Submitted: 4/8/2014 12:56:59 AM : Outperform Start Price: $1.40 GTXI Score: -14.95

With a good-sized dilutive financing out of the way, it becomes a little safer to bottom feed on GTx ahead of topline data from a phase II trial of enobosarm in hormone receptor positive metastatic breast cancer this quarter. The company has already stated they expect to meet the low bar of three clinical responses out of at least fourteen evaluable patients, but the headline of "positive topline data" from a phase II cancer trial should still be enough for a bump from catalyst-starved momo players. GTx is always fun to play because it inevitably gets swatted from whatever heights it improbably ascends to, much to the chagrin of the Seeking Alpha types who repeatedly endorse it.

Recs

2
Member Avatar rknapton (< 20) Submitted: 8/6/2013 7:35:50 PM : Underperform Start Price: $4.24 GTXI Score: +86.75

Short. Biotech. No revenues, burning through cash.

Recs

0
Member Avatar bitsygee (< 20) Submitted: 7/18/2013 5:01:50 PM : Outperform Start Price: $5.63 GTXI Score: -94.79

positive results in phase iii trials.

Recs

0
Member Avatar stainsolution (57.05) Submitted: 4/9/2012 7:45:37 PM : Outperform Start Price: $3.60 GTXI Score: -107.89

Bio play

Recs

0
Member Avatar RBuskey106 (49.36) Submitted: 3/26/2012 10:41:59 AM : Outperform Start Price: $3.54 GTXI Score: -104.13

Biotech----Play on the Chart

Recs

0
Member Avatar KimLanners (< 20) Submitted: 10/14/2011 8:19:06 PM : Outperform Start Price: $4.01 GTXI Score: -131.65

biotech

Recs

0
Member Avatar TraderHater (43.55) Submitted: 11/3/2009 4:55:22 PM : Underperform Start Price: $3.90 GTXI Score: +154.94

These guys are toast

Recs

0
Member Avatar Popnfresh100 (32.97) Submitted: 11/2/2009 12:46:40 PM : Outperform Start Price: $4.88 GTXI Score: -165.29

Glimmers of hope- meeting with the FDA to discuss future rulings, drug has technically not been rejected.

Recs

0
Member Avatar ranchclub (< 20) Submitted: 9/23/2009 12:59:29 PM : Underperform Start Price: $13.03 GTXI Score: +175.20

Pharma company with cancer trials. I bet against curing cancer even though that would be great.

Recs

0
Member Avatar becon800 (99.60) Submitted: 2/6/2009 3:34:46 PM : Outperform Start Price: $11.33 GTXI Score: -220.51

Decision from the FDA by 2/28/08. It would be the first approval of its kind so the stock should rally.

Recs

0
Member Avatar biovestor (< 20) Submitted: 6/28/2008 6:29:53 AM : Outperform Start Price: $14.63 GTXI Score: -151.34

Promisng treatment for prostate cancer in late-stage development likely to fuel gains for GTXI over the next year or so.

Recs

0
Member Avatar crl2007 (87.27) Submitted: 5/29/2008 10:29:12 AM : Outperform Start Price: $15.40 GTXI Score: -139.00

s+p strong buy, reuters rated out-perform, target price $27

Recs

0
Member Avatar johnearl12 (< 20) Submitted: 5/4/2008 9:09:18 PM : Outperform Start Price: $18.21 GTXI Score: -138.91

It has a couple of Phase lll trials going on. It is about ready to pop. Great short term possibilities and great long term too. It has good buzz in the market place. Several reports state it will have unbelievable growth when the products hit the market soon.

Recs

1
Member Avatar DANSEVILLE (< 20) Submitted: 4/10/2008 9:33:25 PM : Outperform Start Price: $15.50 GTXI Score: -144.38

THERE ARE SEVERAL OPTIONS ON THE TABLE NOW. THERE WILL BE AN ANNOUCEMENT APRIL 12-15 CONCERNING THE FINAL TRAILS OF THEIR DRUGS

Recs

1
Member Avatar marinalee (24.26) Submitted: 8/22/2007 5:32:09 AM : Outperform Start Price: $18.49 GTXI Score: -136.19

ready for the gate

Recs

0
Member Avatar sogreek (< 20) Submitted: 7/24/2007 4:38:26 PM : Outperform Start Price: $14.96 GTXI Score: -128.87

has taken a beatin lately...but I am still in love with the pipeline.

Recs

0
Member Avatar iceman7403 (75.78) Submitted: 5/7/2007 5:50:39 PM : Outperform Start Price: $19.82 GTXI Score: -132.91

great pipeline and collaborations with large pharmas

Recs

3
Member Avatar nilknarb194572 (< 20) Submitted: 2/21/2007 12:42:39 PM : Outperform Start Price: $20.50 GTXI Score: -138.22

This drug is presently being tested for the treatment of prostrate cancer.Eight months ago it was tested on my friend along with a sugar pill the cancer is gone.I'm sure this drug is going to be around for a while.

Recs

2
Member Avatar aasp (< 20) Submitted: 1/5/2007 10:25:06 PM : Outperform Start Price: $16.36 GTXI Score: -141.81

Program for mitigation of prostate problems (including cancer) appears to be on track and shows great promise. This stock has no middle ground. It will be a ten bagger or out of business in 5 yrs.

Recs

0
Member Avatar LesMiles (< 20) Submitted: 5/30/2006 10:13:55 PM : Outperform Start Price: $8.57 GTXI Score: -152.82

2 drugs (same drug @ different doses for different effects) in phase iii trials and 1 drug just starting
phase ii trial with another candidate waiting in the wings.

Results 1 - 20 of 20

Featured Broker Partners


Advertisement